California Legislature · 2017-2018 Regular Session
Amended Assembly
AB 1512
Opioid Addiction Prevention and Rehabilitation Act
Author:
Kevin McCarty
(D-AD07)
Latest action:
Amended Assembly
(May 9, 2017)
Current location: CX19 · Desk
Version history
Action history
-
Feb 17, 2017 Read first time. To print. Assembly
-
Feb 19, 2017 From printer. May be heard in committee March 21. Assembly
-
Mar 27, 2017 Referred to Coms. on HEALTH and REV. & TAX. Assembly
-
Mar 28, 2017 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. Assembly
-
Mar 29, 2017 Re-referred to Com. on HEALTH. Assembly
-
Apr 17, 2017 From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. Assembly
-
Apr 18, 2017 Re-referred to Com. on HEALTH. Assembly
-
Apr 19, 2017 From committee: Do pass and re-refer to Com. on REV. & TAX. (Ayes 11. Noes 2.) (April 18). Re-referred to Com. on REV. & TAX. Assembly
-
Apr 24, 2017 In committee: Set, first hearing. Hearing canceled at the request of author. Assembly
-
Apr 25, 2017 From committee chair, with author's amendments: Amend, and re-refer to Com. on REV. & TAX. Read second time and amended. Assembly
-
Apr 26, 2017 Re-referred to Com. on REV. & TAX. Assembly
-
May 9, 2017 From committee chair, with author's amendments: Amend, and re-refer to Com. on REV. & TAX. Read second time and amended. Assembly
-
May 10, 2017 Re-referred to Com. on REV. & TAX. Assembly
-
May 15, 2017 In committee: Set, second hearing. Testimony taken. Assembly
-
Jan 31, 2018 Died pursuant to Art. IV, Sec. 10(c) of the Constitution. Assembly
-
Feb 1, 2018 From committee: Filed with the Chief Clerk pursuant to Joint Rule 56. Assembly
Lobbying activity
FPPC lobbying disclosures whose activity descriptions mention AB 1512, scoped to filings whose coverage period extends through or beyond this bill's introduction date.
Note: CalAccess lobby filings reference bills by measure number only — no session tag. When the same measure number has existed in earlier sessions (e.g. a previously chaptered bill still being lobbied on for implementation), some of those filings may appear here even though they relate to a different bill. Use the activity descriptions to disambiguate.
| Period | Form | Filer | Firm / Employer | Lobbying Activity | Filing |
|---|---|---|---|---|---|
| 01/01/2019–03/31/2019 | Employer Report | CALIFORNIA ASSOCIATION FOR IB WORLD SCHOOLS | CALIFORNIA ASSOCIATION FOR IB WORLD SCHOOLS | AB 1512 AB 1233 Legislature CDE SBE | #2377295 |
| 01/01/2019–03/31/2019 | Employer Report | SAN JOSE - EVERGREEN COMMUNITY COLLEGE DISTRICT | SAN JOSE - EVERGREEN COMMUNITY COLLEGE DISTRICT | AB 2, AB 8, AB 23, AB 30, AB 48, AB 70, AB 151, AB 244, AB 260, AB 302, AB 522, AB 540, AB 541, AB 542, AB 720, AB 806, AB 1303, AB 1314, AB 1427, AB 1512, AB 1645, AB 1689, AB 1739, AB 1741, SB 5, SB 12, SB 52, SB 150, SB 291, SB 296, SB 461, SB 563, SB 568, SB 575, SB 660, SB 713, Legislature re: Community Colleges budget proposals | #2381469 |
| 10/01/2018–12/31/2018 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 315, 444, 587, 595, 1368, 1512, 1752, 1860, 1919, 1992, 1998, 2029, 2303, 2346, 2395, 2486, 2490, 2499, 2517, 2560, 2674, 2741, 2789, 2863, 3087, 3138; ACR 162; ACA 22; SB 199, 212, 437, 562, 790, 826, 945, 993, 1021, 1121, 1156, 1398, 1426; SCR: 100, 109 | #2349758 |
| 07/01/2018–09/30/2018 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 315, 444, 587, 595, 1368, 1512, 1752, 1860, 1919, 1992, 1998, 2029, 2303, 2346, 2395, 2486, 2490, 2499, 2517, 2560, 2674, 2741, 2789, 2863, 3087, 3138; ACR 162; ACA 22; SB 199, 212, 437, 562, 790, 826, 945, 993, 1021, 1121, 1156, 1398, 1426; SCR: 100, 109 | #2317338 |
| 07/01/2018–09/30/2018 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 2384, 2486, 3087; SB 212; AB 1512; AB 212, 315; AB 1860, 2863; ACR 175; SB 826, 945, 1021; SB 17 IMPLEMENTATION; AB 374, AB 1512, SB 1121, SB 456, 790 | #2319695 |
| 04/01/2018–06/30/2018 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 315, 444, 587, 595, 1368, 1512, 1752, 1860, 1919, 1992, 1998, 2029, 2303, 2346 2395, 2486, 2490, 2499, 2517, 2560, 2674, 2741, 2789, 2863, 3087, 3138; ACR 162; ACA 22; SB 199, 212, 437, 562, 790, 826, 945, 993, 1021, 1156, 1398, 1426; SCR: 100, 109 | #2274670 |
| 04/01/2018–06/30/2018 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 2384, 2486, 3087; SB 212; AB 1512; AB 212, 315; AB 1860, 2863; ACR 175; SB 826, 945, 1021; SB 17 IMPLEMENTATION | #2270364 |
| 01/01/2018–03/31/2018 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512, 1751, 1752, 1753, 1963, 1998, 2174, 2256, 2384, 2486, 2487, 2741, 2760, 2789, 2804, 2859, 2861 and SB 17, 212, 443, 1103, 1109, 1229, 1240 and Opioid Abuse Policy and ePrescribing legislation | #2237362 |
| 01/01/2018–03/31/2018 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 315, 444, 587, 595, 1368, 1512, 1752, 1860, 1919, 1992, 1998, 2029, 2303, 2395, 2490, 2499, 2560, 2674, 2741, 2789, 2863, 3138; ACR 162; ACA 22; SB 199, 212, 437, 562, 790, 945, 993, 1021, 1156, 1398, 1426; SCR: 109 | #2243229 |
| 01/01/2018–03/31/2018 | Employer Report | TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA, INC. | AB 1512 | #2238826 |
| 10/01/2017–12/31/2017 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: Pharmaceutical Pricing, AB 43, 182, 315, 444, 447, 587, 715, 1512, SB 641 | #2208097 |
| 10/01/2017–12/31/2017 | Employer Report | CARDINAL HEALTH, INC. | CARDINAL HEALTH, INC. | AB 401, 444, 514, 1512; SB 212 | #2209912 |
| 10/01/2017–12/31/2017 | Employer Report | COUNTY BEHAVIORAL HEALTH DIRECTORS ASSOCIATION (CBHDA) | COUNTY BEHAVIORAL HEALTH DIRECTORS ASSOCIATION (CBHDA) | AB74 AB89 AB182 AB205 AB208 AB210 AB236 AB244 AB285 AB318 AB340 AB350 AB372 AB395 AB451 AB470 AB488 AB501 AB502 AB532 AB575 AB620 AB700 AB720 AB727 AB850 AB917 AB935 AB1054 AB1095 AB1135 AB1250 AB1308 AB1315 AB1340 AB1372 AB1406 AB1512 AB1539 AB1603 AB1606 AB1643 AB1650 AB1688 SB8 SB34 SB142 SB171 SB191 SB192 SB223 SB323 SB350 SB374 SB384 SB409 SB636 SB641 SB684 SB688 SB725 SB786 SCA12 SCR54 SCR65 | #2208684 |
| 10/01/2017–12/31/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy and ePrescribing legislation | #2208210 |
| 10/01/2017–12/31/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACR 14, 18; ACA 4; SB 17, 199, 212, 419, 562, 567, 641, 790 | #2211571 |
| 10/01/2017–12/31/2017 | Employer Report | PURDUE PHARMA LP | PURDUE PHARMA LP | Legislature: AB 1512. | #2209756 |
| 07/01/2017–09/30/2017 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: Pharmaceutical Pricing, AB 40, 43, 182, 265, 315, 401, 444, 447, 587, 715, 1048, 1512, SB 17, 176, 315, 510, 641 | #2191806 |
| 07/01/2017–09/30/2017 | Employer Report | CLEAN SLATE CENTERS | — | AB 182; 186; 395; 572; 715; 1048; 1512 SB 4; 323; 395; 554; 641; 786 | #2193323 |
| 07/01/2017–09/30/2017 | Employer Report | COUNTY BEHAVIORAL HEALTH DIRECTORS ASSOCIATION (CBHDA) | COUNTY BEHAVIORAL HEALTH DIRECTORS ASSOCIATION (CBHDA) | AB74 AB89 AB182 AB205 AB208 AB210 AB236 AB244 AB285 AB318 AB340 AB350 AB372 AB395 AB451 AB470 AB488 AB501 AB502 AB532 AB575 AB620 AB700 AB720 AB727 AB850 AB917 AB935 AB1054 AB1095 AB1135 AB1250 AB1308 AB1315 AB1340 AB1372 AB1406 AB1512 AB1539 AB1603 AB1606 AB1643 AB1650 AB1688 SB8 SB34 SB142 SB171 SB191 SB192 SB223 SB323 SB350 SB374 SB384 SB409 SB636 SB641 SB684 SB688 SB725 SB786 SCA12 SCR54 SCR65 | #2191908 |
| 07/01/2017–09/30/2017 | Employer Report | MATSON NAVIGATION COMPANY, INC. | MATSON NAVIGATION COMPANY, INC. | AB 13, 734, 1152, 1317, 1383, 1418, 1512, SB 639, 644, 660 | #2187244 |
| 07/01/2017–09/30/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy | #2193702 |
| 07/01/2017–09/30/2017 | Employer Report | MYLAN INC. | MYLAN INC. | Legislature: SB 17; SB 212; AB 444; AB 1512 | #2191520 |
| 07/01/2017–09/30/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACR 14, 18; ACA 4; SB 17, 199, 212, 419, 562, 567, 641, 790 | #2192577 |
| 07/01/2017–09/30/2017 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 17, 715; SB 17, 790, 212; AB 265, 315, 1512 | #2190332 |
| 04/01/2017–06/30/2017 | Employer Report | ABBVIE | ABBVIE | AB 265, 587, 1512; SB 17, 790 | #2175552 |
| 04/01/2017–06/30/2017 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: Pharmaceutical Pricing, AB 40, 43, 182, 265, 315, 444, 447, 587, 1048, 1512, 17, 176, 315, 510, 641 | #2173833 |
| 04/01/2017–06/30/2017 | Employer Report | BIOCOM | — | SCA 7, AB 182, AB 600, SB 600, SB 790, AB 1512, SB 562, SB 567, AB 602, SB 327, SB 212, AB 444, Drugs & Sharps waste disposal , SB 17, AB 265 Administration: BIO convention in San Diego, AB 265, SB 17, SB 790 | #2176878 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA CONSORTIUM OF ADDICTION PROGRAMS AND PROFESSIONALS | — | AB 285; AB 1512; SB 786; SB 374; State Funding for Addiction; AB 532; AB 700; Tax on Opioids; AB 186; AB 182; General Health Legislation; SB 323; SB 636; AB 1668. | #2171514 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA COUNCIL OF COMMUNITY BEHAVIORAL HEALTH AGENCIES | CALIFORNIA COUNCIL OF COMMUNITY MENTAL HEALTH AGENCIES | AB74AB182AB186AB208AB210Ab232AB244AB266AB296AB340AB395AB456AB470AB501AB620AB665AB675AB683AB715AB720AB727AB824AB850AB860AB917AB1074AB1095AB1134AB1136AB1188AB1340Ab1353AB1362AB1368AB1512AB1560SB8Sb34Sb142Sb143SB191SB215Sb218Sb222Sb237SB374Sb409SB636SB786 | #2169141 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA PHARMACISTS ASSOCIATION | CALIFORNIA PHARMACISTS ASSOCIATION | AB 40, 315, 401, 602, 1048, 1512; SB 17, 419, 443, 641, 716, 752, 790; LEGISLATURE, BOARD OF PHARMACY: TRAILER BILL LEGISLATION 645, PHARMACY COMPOUNDING REGULATIONS | #2174540 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA PRIMARY CARE ASSOCIATION AND AFFILIATED ENTITY CALIFORNIA HEALTH+ ADVOCATES | — | Prop 56, SB 192, AB 1315, AB 562, SB 323, SB 456, AV1315, SB 323, AB 224, AB 387, AB 391, AB 447, AB 1560, AB 1512, AB 508, AB 1591, AB 827, SB 309, SB 743, SB 790, AB 10, AB 834, AB 391, AB 447, AB 401, AB 21, AB 343, AB 279, AB 391, AB 508, AB 569, AB 834, AB 916, SB 162, SB 309, AB 396, SB 222, SB 309, SB 369, SB 743, AB 1005, AB21, AB 1252, AB 343, SB 29, SB 244, AB 860, AB 164, AB 447, | #2167078 |
| 04/01/2017–06/30/2017 | Employer Report | CALIFORNIA TAXPAYERS ASSOCIATION AND AFFILIATED ENTITY CALIFORNIA TAX FOUNDATION | — | CALIFORNIA STATE LEGISLATURE REGARDING: AB 102, AB 195, AB 433, AB 449, AB 454, AB 479, AB 525, AB 600, AB 747, AB 804, AB 805, AB 989, AB 1003, AB 1171, AB 1347, AB 1356, AB 1512, AB 1613, SB 66, SB 86, SB 567, SB 703 AND ACA 4. | #2174094 |
| 04/01/2017–06/30/2017 | Employer Report | CARDINAL HEALTH, INC. | — | AB 45, 401, 444, 1512; SB 17, 212, 790 | #2175219 |
| 04/01/2017–06/30/2017 | Employer Report | CLEAN SLATE CENTERS | — | AB 532; 715; 1048; 1512 SB 34; 323; 554; 641; 786; 799 | #2175490 |
| 04/01/2017–06/30/2017 | Employer Report | Daiichi Sankyo Inc. | DAIICHI SANKYO INC. | Legislature: AB 265; AB 1512; SB 17; SB 790. | #2171597 |
| 04/01/2017–06/30/2017 | Employer Report | ENDO | — | Legislature: AB29, AB265, AB315, AB1512, SB17, SB790 | #2173311 |
| 04/01/2017–06/30/2017 | Employer Report | EXPRESS SCRIPTS HOLDING COMPANY | — | Legislature: AB 29, AB 265, AB 315, AB 1353, AB 1512. Governor's Office: AB 315. Department of Managed Health Care: AB 315. Department of Finance: AB 315. Health and Human Services Agency: AB 315. | #2167977 |
| 04/01/2017–06/30/2017 | Employer Report | GATEKEEPER INNOVATIONS | GATEKEEPER INNOVATIONS | AB 175, 182, 1512; SB 419; LEGISLATURE RE: OPIOID ABUSE | #2174865 |
| 04/01/2017–06/30/2017 | Employer Report | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | INSPERITY SERVICES, L.P. | AB 1, 29, 265, 315, 444, 1107, 1512; ACR 11; SB 1, 17, 212, 567, 790 | #2173998 |
| 04/01/2017–06/30/2017 | Employer Report | HEALTHCARE DISTRIBUTION ALLIANCE (HDA) | HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | AB 1512; LEGISLATURE, OFFICE OF EMERGENCY SERVICES RE: SHARPS TAKEBACK | #2172983 |
| 04/01/2017–06/30/2017 | Employer Report | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | AB 265, 514, 602, 1512; SB 17, 258, 327, 567, 790; DEPARTMENT OF TOXIC SUBSTANCES CONTROL - RETAIL WASTE, TOXICITY TESTING, THE SAFER CONSUMER PRODUCTS PROGRAM AND AA GUIDANCE DOCUMENT | #2174478 |
| 04/01/2017–06/30/2017 | Employer Report | MALLINCKRODT, LLC | — | AB 265, AB 1512, SB 17; SB 790 | #2171605 |
| 04/01/2017–06/30/2017 | Employer Report | MATSON NAVIGATION COMPANY, INC. | MATSON NAVIGATION COMPANY, INC. | AB 1, 13, 301, 734, 462, 734, 962, 1152, 1317, 1383, 1418, 1512, 1561, SB 1, 639, 644, 660 | #2169970 |
| 04/01/2017–06/30/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature, Governor's Office re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 419, 443, 567 and Opioid Abuse Policy | #2170068 |
| 04/01/2017–06/30/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACR 14, 18; ACA 4; SB 17, 199, 212, 419, 562, 641, 790; Patient Access and Transparency | #2171820 |
| 04/01/2017–06/30/2017 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 29, 265, 1512; SB 17, 790; AB 715, 1386 | #2172782 |
| 04/01/2017–06/30/2017 | Employer Report | PURDUE PHARMA LP | PURDUE PHARMA LP | Legislature: AB 715; AB 1512; SB 17; SB 419; SB 790. | #2169959 |
| 04/01/2017–06/30/2017 | Employer Report | SAN DIEGO METROPOLITAN TRANSIT SYSTEM | — | Governor?s Office, Caltrans, CTC, CalSTA, Budget Bills: AB 17, 25, 33, 46, 52, 65, 66, 73, 87, 91, 92, 151, 168, 174, 278, 281, 287, 302, 330, 344, 351, 352, 378, 398, 399, 419, 467, 468, 515, 555, 623, 673, 730, 758, 805, 1060, 1073, 1113, 1121, 1160, 1233, 1259, 1324, 1363, 1421, 1427, 1442, 1444, 1509, 1512, 1640, 1652, 1679, SB 1, 4, 20, 21, 22, 41, 53, 54, 65, 137, 145, 174, 185, 200, | #2171138 |
| 04/01/2017–06/30/2017 | Employer Report | TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA, INC. | AB 1512, SB 17, 790 | #2171919 |
| 04/01/2017–06/30/2017 | Employer Report | UNITED HEALTHCARE SERVICES, INC. | — | AB 29, AB 156, AB 182, AB 265, AB 315, AB 401, AB 532, AB 587, AB 715, AB 904, AB 1353, AB 1512, SB 17, SB 43, SB 133, SB 134, SB 199, SB 221, SB 315, SB 419, SB 437, SB 443, SB 476, SB 510, SB 528, SB 562, SB 608, SB 641, Department of HealthCare Services regarding MediCal program, and CalPers. | #2169148 |
| 01/01/2017–03/31/2017 | Employer Report | ABBVIE | ABBVIE | AB 265, 587, 1107, 1512; SB 17, 567, 790 | #2154148 |
| 01/01/2017–03/31/2017 | Employer Report | AEGIS Treatment Centers LLC & Its Affiliated Entities | AEGIS Treatment Centers LLC & Its Affiliated Entities | AB 395; AB 1512; Drug Medi-Cal Funding | #2155626 |
| 01/01/2017–03/31/2017 | Employer Report | AMERISOURCEBERGEN CORPORATION | — | Board of Pharmacy re: Pharmaceutical Product Stewardship Programs, Compounding; Legislature re: AB 29, 43, 182, 315, 587, 715, 1512, SB 212, 265, 510, Pharmaceutical Pricing | #2154327 |
| 01/01/2017–03/31/2017 | Employer Report | ASTELLAS PHARMA US, INC. | — | Legislature regarding AB 29, AB 315, AB 265, AB 587, AB 107, AB 1512, SB 17, SB 462, SB 790. | #2153208 |
| 01/01/2017–03/31/2017 | Employer Report | BIOCOM | — | Legislature: AB 182, AB 265, AB 602, AB 1512, SB 790. AB 444, SB 17, SB 212, Opening of Biocom office in LA, BIO Convention in San Diego Administration: BIO convention in San Diego | #2156910 |
| 01/01/2017–03/31/2017 | Employer Report | BIOGEN | BIOGEN IDEC | Legislature: SB 17; SB 23; SB 440; SB 419; AB 265; AB 315; AB 1512; AB 624; AB 602; AB 207; AB 182; AB 845; AB 613. | #2155439 |
| 01/01/2017–03/31/2017 | Employer Report | CALIFORNIA COUNCIL OF COMMUNITY BEHAVIORAL HEALTH AGENCIES | CALIFORNIA COUNCIL OF COMMUNITY MENTAL HEALTH AGENCIES | AB74AB182AB186AB208AB210Ab232AB244AB266AB296AB340AB395AB456AB470AB501AB620AB665AB675AB683AB715AB720AB727AB824AB850AB860AB917AB1074AB1095AB1134AB1136AB1188AB1340Ab1353AB1362AB1368AB1512AB1560SB8Sb34Sb142Sb143SB191SB215Sb218Sb222Sb237SB374Sb409SB636SB786 | #2152917 |
| 01/01/2017–03/31/2017 | Employer Report | CALIFORNIA PHARMACISTS ASSOCIATION | CALIFORNIA PHARMACISTS ASSOCIATION | AB 315, 401, 602, 1512; SB 641 | #2156486 |
| 01/01/2017–03/31/2017 | Employer Report | CARDINAL HEALTH, INC. | — | AB 401, 1512; SB 17 | #2157192 |
| 01/01/2017–03/31/2017 | Employer Report | COUNTY BEHAVIORAL HEALTH DIRECTORS ASSOCIATION (CBHDA) | COUNTY BEHAVIORAL HEALTH DIRECTORS ASSOCIATION (CBHDA) | AB74, AB89, AB182, AB208, AB210, AB236, AB244, AB285, AB340, AB350, AB372, AB395, AB451, AB470, AB488, AB501, AB502, AB575, AB620, AB700, AB727, AB850, AB1054, AB1095, AB1135, AB1372, AB1406, AB1512, AB1539, AB1606, AB1643, AB1650, ACR8, SB34, SB54, SB192, SB323, SB384, SB409, SB565, SB636, SB641, SB684, SB688, SB725, SB786 | #2154028 |
| 01/01/2017–03/31/2017 | Employer Report | Daiichi Sankyo Inc. | DAIICHI SANKYO INC. | Legislature: AB 265 and AB 1512. | #2153053 |
| 01/01/2017–03/31/2017 | Employer Report | ENDO | — | Legislature: AB29, AB265, AB315, AB1512, SB17 | #2157264 |
| 01/01/2017–03/31/2017 | Employer Report | GATEKEEPER INNOVATIONS | GATEKEEPER INNOVATIONS | AB 175, 182, 715, 823, 1512 | #2156418 |
| 01/01/2017–03/31/2017 | Employer Report | GENENTECH, INC., A MEMBER OF THE ROCHE GROUP | INSPERITY SERVICES, L.P. | AB 1, 29, 265, 315, 401, 444, 1107, 1512; ACR 11; SB 1, 17, 212, 567, 790 | #2157873 |
| 01/01/2017–03/31/2017 | Employer Report | INDEPENDENT PHARMACY COOPERATIVE | INDEPENDENT PHARMACY COORPERATIVE | AB 315, 602, 1512; SB 641 | #2155221 |
| 01/01/2017–03/31/2017 | Employer Report | MALLINCKRODT, LLC | — | AB 265, AB 1512, SB 17 | #2152263 |
| 01/01/2017–03/31/2017 | Employer Report | MC KESSON CORPORATION | — | Legislature re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 176, 212, 419, 443 | #2156117 |
| 01/01/2017–03/31/2017 | Employer Report | Pfizer Inc. | Pfizer Inc. | AB: 29, 40, 182, 186, 265, 315, 444, 587, 715, 904, 1048, 1107, 1353, 1368, 1512; ACA: 4; ACR: 14, 18; SB: 17, 199, 212, 419, 562, 567, 641, 790; Cancer Treatment Engagement | #2154559 |
| 01/01/2017–03/31/2017 | Employer Report | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | AB 265; SB 17; AB 315, AB 1512; SB 17; AB 444 | #2156933 |
| 01/01/2017–03/31/2017 | Employer Report | PURDUE PHARMA LP | PURDUE PHARMA LP | Legislature: AB 715; AB 1048; AB 1512; SB 419. | #2155423 |
| 01/01/2017–03/31/2017 | Employer Report | TEVA PHARMACEUTICALS USA, INC. | TEVA PHARMACEUTICALS USA, INC. | AB 1512, SB 17 | #2153001 |
| Period | Form | Employer | Firm / Filer | Fees | Reimb. | Period Total | Cumulative | Lobbying Activity | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 01/01/2019–03/31/2019 | Firm Activity (payments) | CALIFORNIA ASSOCIATION FOR IB WORLD SCHOOLS | CAPITOL ADVISORS GROUP LLC | $1,500 | $0 | $1,500 | $1,500 | AB 1512 AB 1233 Legislature CDE SBE | #2377494 |
| 07/01/2018–09/30/2018 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $43,000 | $0 | $43,000 | $285,787 | Legislature // AB374 AB1512 SB212 SB1121 | #2315816 |
| 04/01/2018–06/30/2018 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $43,000 | $0 | $43,000 | $242,787 | Legislature // AB1512 AB2486 AB3087 SB212 | #2264880 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $126,190 | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512, 1751, 1752, 1753, 1963, 1998, 2174, 2256, 2384, 2486, 2487, 2741, 2760, | #2236701 |
| 01/01/2018–03/31/2018 | Firm Activity (payments) | Teva Pharmaceuticals USA, Inc. | Aaron Read & Associates, LLC | $16,000 | $558 | $16,558 | $136,558 | AB 1512 | #2239682 |
| 10/01/2017–12/31/2017 | Employer Payments to Firms | Matt Back Government Relations | PURDUE PHARMA LP | $21,000 | $1,023 | $22,023 | $85,023 | Legislature: AB 1512. | #2209756 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $102,565 | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy and ePrescribing legislation | #2208940 |
| 10/01/2017–12/31/2017 | Firm Activity (payments) | Purdue Pharma LP | Matt Back Government Relations | $21,000 | $1,023 | $22,023 | $85,023 | Lobbied the Legislature regarding AB 1512. | #2205337 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Cal Capitol Group | TSOU CONSULTING, LLC | $16,200 | $0 | $16,200 | $41,458 | CleanSlate: SB 554, AB 182, AB 186, AB 572, AB 715, AB 1048, AB 1512, SB 4, AB 395, SB 323, SB 395, SB 641, SB 786 | #2187781 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Life Sciences Association | Gonzalez Government Consulting | $18,000 | — | $18,000 | $60,000 | Bills lobbied: AB 29, AB 97, AB 182, AB 186, AB 207, AB 315, AB 265, AB 447, AB 479, AB 602, AB 613, AB 845, AB 889, AB 1512, ACA 4, SB 17, SB 97, SB 327, SB 419, SB 567, SB 790. | #2194393 |
| 04/01/2017–09/30/2017 | Firm Activity (payments) | CALIFORNIA PRIMARY CARE ASSOCIATION AND AFFILIATED ENTITY CALIFORNIA HEALTH+ ADVOCATES | CAPITOL CONNECTION | $45,000 | $0 | $45,000 | $90,000 | AB 97, AB 113, AB 387, AB 401, AB 447, AB 1512, AB 1560, AB 1591, SB 43, SB 54, SB 97, SB 191, SB 323, SB 456, SB 562, SB 743, SB 790 | #2177484 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | California Society of Addiction Medecine | HARRIS & WENBOURNE LLC | $8,500 | $0 | $8,500 | $25,830 | DCA, DHCS, H&HS AGENCY, Legislature Physicians Health Program; State Budget, MBC, CURES21 grant, AB186, AB208, AB285, AB395, AB497, AB505, AB715, AB751, AB844, AB850, AB1095, AB1215, AB1512, AB1578, | #2194470 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CAPITOL ADVOCACY, LLC ON BEHALF OF UNITED HEALTHCARE | WEST COAST ADVISORS | $10,000 | $0 | $10,000 | $35,000 | AB 29, 156, 157, 182, 265, 315, 401, 532, 587, 715, 904, 1353, 1512; SB 17, 43, 133, 134, 221, 315, 419, 437, 443, 476, 510, 528, 608, 641 | #2192674 |
| 07/01/2017–09/30/2017 | Employer Payments to Firms | Capitol Partners Inc. | MYLAN INC. | $14,000 | $0 | $14,000 | $49,000 | Legislature: SB 17; SB 212; AB 444; AB 1512. | #2191520 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | CleanSlate Centers | CAL CAPITOL GROUP | $48,000 | $0 | $48,000 | $108,000 | AB 182; 186; 395; 572; 715; 1048; 1512 SB 4; 323; 395; 641; 786 | #2194095 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | MATSON NAVIGATION COMPANY, INC. | Aaron Read & Associates, LLC | $9,000 | $0 | $9,000 | $36,000 | AB 13, 734, 1152, 1317, 1383, 1418, 1512, SB 639, 644, 660 | #2191262 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $0 | $23,625 | $78,940 | Legislature, Governor's Office, Board of Pharmacy re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 443 and Opioid Abuse Policy | #2193778 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Mylan, Inc. | Capitol Partners, LLC | $14,000 | $0 | $14,000 | $49,000 | SB 17, SB 212, AB 444, AB 1512 | #2193497 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $48,000 | $1,220 | $49,220 | $145,220 | CALIFORNIA STATE LEGISLATURE REGARDING: SB 17, SB 212, SB 419, SB 790, AB 265, AB 587, AB 715, AB 1353, AB 1512. | #2193062 |
| 07/01/2017–09/30/2017 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $39,250 | $0 | $39,250 | $118,261 | LEGISLATURE // AB265 AB315 AB1512 SB17 SB790 | #2189164 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Ackler & Associates | DAIICHI SANKYO INC. | $17,400 | $0 | $17,400 | $34,800 | Legislature: AB 265; AB 1512; SB 17; SB 790. | #2171597 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Amerisource Bergen Corporation | CALIFORNIA STRATEGIES & ADVOCACY, LLC | $21,000 | $0 | $21,000 | $49,000 | Board of Pharmacy re: Pharmacutical Product Stewardship Programs Compounding. Legislature re: Phamaceutical Pricing, AB 40, 43, 182, 265, 315, 444, 447, 587, 1048, 1512, SB 17, 176, 315, 510, 641 | #2176210 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | BIOCOM | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $28,000 | $0 | $28,000 | $53,500 | AB 182, 265, 444, 600, 602, 1512; SB 17, 212, 327, 562, 567, 600, 790; SCA 7; LEGISLATURE RE: DRUGS & SHARPS WASTE DISPOSAL | #2174845 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CALIFORNIA CONSORTIUM OF ADDICTION PROGRAMS AND PROFESSIONALS | KAHN, SOARES & CONWAY, LLP | $5,000 | $94 | $5,094 | $14,599 | AB 285; AB 1512; SB 786; SB 374; State Funding for Addiction; AB 532; AB 700; Tax on Opioids; AB 186; AB 182; General Health Legislation; SB 323; SB 636; AB 1668. | #2171542 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | California Life Sciences Association | Gonzalez Government Consulting | $24,000 | — | $24,000 | $42,000 | Bills lobbied: AB 29, AB 182, AB 186, AB 207, AB 315, AB 265, AB 447, AB 479, AB 602, AB 613, AB 845, AB 889, AB 1512, ACA 4, SB 17, SB 97, SB 327, SB 419, SB 567. SB 790. | #2177259 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CALIFORNIA LIFE SCIENCES ASSOCIATION (CLSA) | CARPENTER SIEVERS LLC | $46,000 | $2,348 | $48,348 | $71,423 | AB 29, 43, 182, 186, 207, 315, 265, 444, 447, 479, 602,613, 845, 889, 1107, 1386, 1512; ACA 4; ACR 11, 14; HR 21; SB 17, 23, 66, 327, 419, 440, 567, 790; SCR 27, 29; SR 15, 34, 37 | #2176130 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CALIFORNIA PHARMACISTS ASSOCIATION | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $26,000 | $2,165 | $28,165 | $36,631 | AB 315, 1048, 1512; SB 419, 641, 716, 790 | #2176109 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | California Society of Addiction Medecine | HARRIS & WENBOURNE LLC | $8,500 | $0 | $8,500 | $16,830 | DCA, DHCS, H&HS AGENCY, Legislature Physicians Health Program; State Budget, MBC, CURES21 grant, AB186, AB208, AB285, AB395, AB497, AB505, AB715, AB751, AB844, AB850, AB1095, AB1215, AB1512, AB1578, | #2177237 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CAPITOL ADVOCACY, LLC ON BEHALF OF UNITED HEALTHCARE | WEST COAST ADVISORS | $20,000 | $0 | $20,000 | $25,000 | AB 29, 156, 157, 182, 265, 315, 401, 532, 587, 715, 904, 1353, 1512; SB 17, 43, 133, 134, 221, 315, 419, 437, 443, 476, 510, 528, 608, 641 | #2174718 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CARDINAL HEALTH & AFFILIATED ENTTIES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $25,500 | $182 | $25,682 | $53,774 | AB 401, 1512 | #2176109 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | CleanSlate Centers | CAL CAPITOL GROUP | $36,000 | $0 | $36,000 | $60,000 | AB 532; 715; 1512 SB 34; 323; 419; 554; 641; 786; 799 | #2175684 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Community Associations Institute - California Legislative Action Committee | KAHN, SOARES & CONWAY, LLP | $27,000 | $75 | $27,075 | $54,075 | AB 1426; AB 913; SB 407; SB 721; AB 1421; AB 534; AB 731; AB 1423; AB 1412; Fair Housing; SB 522; AB 634; SB 451; AB 1512. | #2171542 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Daiichi Sankyo | ACKLER & ASSOCIATES | $17,400 | $0 | $17,400 | $34,800 | AB 265 AB 1512 SB 17 SB 790 | #2172645 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $15,000 | $0 | $15,000 | $23,000 | Legislature: AB29, AB265, AB315, AB1512, SB17, SB790 | #2176382 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | EXPRESS SCRIPTS HOLDING COMPANY | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $18,000 | $0 | $18,000 | $36,000 | AB 29, 315, 1353, 1512 | #2174845 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | GATEKEEPER INNOVATIONS | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $7,500 | $0 | $7,500 | $15,000 | AB 175, 182, 1512; SB 419; LEGISLATURE RE: OPIOID ABUSE | #2174845 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | HEALTHCARE DISTRIBUTION ALLIANCE (HDMA) | POLITICAL SOLUTIONS, LLC | $25,500 | $146 | $25,646 | $51,146 | AB 1512; LEGISLATURE, OFFICE OF EMERGENCY SERVICES RE: SHARPS TAKEBACK | #2175236 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | JOHNSON & JOHNSON SERVICES, INC. AND AFFILIATED ENTITIES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $11,262 | $412 | $11,674 | $17,969 | AB 265, 1512; SB 17, 327, 567, 790 | #2176109 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | MALLINCKRODT, LLC | NOTEWARE GOVERNMENT RELATIONS | $24,000 | $0 | $24,000 | $42,000 | AB 265, AB 1512, SB 17, SB 790 | #2169554 |
| 04/01/2017–06/30/2017 | Employer Payments to Firms | Matt Back Government Relations | PURDUE PHARMA LP | $21,000 | $0 | $21,000 | $42,000 | Legislature: AB 715; AB 1512; SB 17; SB 419; SB 790. | #2169959 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $23,625 | $109 | $23,734 | $55,315 | Legislature, Governor's Office re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 212, 419, 443, 567 and Opioid Abuse Policy | #2169977 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $48,000 | $0 | $48,000 | $96,000 | CALIFORNIA STATE LEGISLATURE REGARDING: SB 17, SB 212, SB 419, SB 790, AB 265, AB 587, AB 715, AB 1353, AB 1512. | #2173958 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $39,250 | $0 | $39,250 | $79,011 | LEGISLATURE // AB29 AB265 AB1512 SB17 SB790 | #2169471 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | NOTEWARE GOVERNMENT RELATIONS | $46,750 | $0 | $46,750 | $83,027 | AB 265, AB 715, AB 1386, AB 1512; SB 17, SB 790 | #2169554 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Purdue Pharma LP | Matt Back Government Relations | $21,000 | $0 | $21,000 | $42,000 | Lobbied the Legislature regarding AB 715, AB 1512, SB 17, SB 790 and SB 419. | #2172040 |
| 04/01/2017–06/30/2017 | Firm Activity (payments) | Teva Pharmaceuticals USA, Inc. | Aaron Read & Associates, LLC | $24,000 | $0 | $24,000 | $56,000 | AB 1512, SB 17, 790 | #2173751 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Ackler & Associates | DAIICHI SANKYO INC. | $17,400 | $0 | $17,400 | $17,400 | Legislature: AB 265 and AB 1512. | #2153053 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | AEGIS TREATMENT CENTERS LLC & ITS AFFILIATED ENTITITES | LANG HANSEN O'MALLEY AND MILLER GOVERNMENTAL RELATIONS | $30,000 | $0 | $30,000 | $30,000 | AB 395; AB 1512; DRUG MEDI-CAL FUNDING | #2156223 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Amerisource Bergen Corporation | CALIFORNIA STRATEGIES & ADVOCACY, LLC | $28,000 | $0 | $28,000 | $28,000 | Board of Pharmacy re: Pharmacutical Product Stewardship Programs Compounding. Legislature re: Phamaceutical Pricing, AB 29 43, 182, 315, 587, 715, 1512, SB 212, 265, 510 | #2158126 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Astellas Pharma US, Inc. | MANATT, PHELPS & PHILLIPS, LLP | $36,000 | $41 | $36,041 | $36,041 | AB 29, AB 315, AB 265, AB 587, AB 1107, AB 1512, SB 17, SB 462, SB 790 | #2157850 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | California Life Sciences Association | Gonzalez Government Consulting | $18,000 | — | $18,000 | $18,000 | Bills lobbied: AB 29, AB 182, AB 186, AB 207, AB 315, AB 265, AB 477, AB 479, AB 602, AB 613, AB 845, AB 889, AB 1512, ACA 4, SB 17, SB 327, SB 419, SB 567. | #2157996 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CALIFORNIA LIFE SCIENCES ASSOCIATION (CLSA) | CARPENTER SIEVERS LLC | $23,000 | $75 | $23,075 | $23,075 | AB 29, 43, 182, 186, 207, 315, 265, 444, 447, 479, 602, 613, 845, 889, 1512; ACA 4; ACR 11, 14; HR 8, 21; SB 17, 23, 66, 212, 327, 419, 440, 567; SCR 27, 29; SR 15 | #2156604 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CALIFORNIA PHARMACISTS ASSOCIATION | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $8,388 | $78 | $8,466 | $8,466 | AB 315, 401, 602, 1512; SB 641 | #2157665 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | California Society of Addiction Medecine | HARRIS & WENBOURNE LLC | $8,330 | $0 | $8,300 | $8,300 | DCA, DHCS, H&HS AGENCY, Legislature Physicians Health Program; State Budget, MBC, CURES21 grant, AB186, AB208, AB285, AB395, AB497, AB505, AB715, AB751, AB844, AB850, AB1095, AB1215, AB1512, AB1578, | #2156802 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CAPITOL ADVOCACY, LLC ON BEHALF OF UNITED HEALTHCARE | WEST COAST ADVISORS | $5,000 | $0 | $5,000 | $5,000 | AB 29, 156, 157, 182, 265, 315, 401, 479, 532, 587, 715, 904, 1353, 1512; SB 17, 43, 133, 134, 221, 315, 419, 437, 443, 476, 510, 528, 608, 641 | #2156553 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | CARDINAL HEALTH & AFFILIATED ENTTIES | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $28,000 | $92 | $28,092 | $28,092 | AB 401, 1512; SB 17 | #2157665 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Daiichi Sankyo | ACKLER & ASSOCIATES | $17,400 | $0 | $17,400 | $17,400 | AB 265 AB 1512 | #2155689 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Endo | WILKE, FLEURY, HOFFELT, GOULD & BIRNEY, LLP | $8,000 | $0 | $8,000 | $8,000 | Legislature: AB29, AB265, AB315, AB1512, SB17 | #2157498 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | GATEKEEPER INNOVATIONS | SLOAT HIGGINS JENSEN AND ASSOCIATES, LLC | $7,500 | $0 | $7,500 | $7,500 | AB 175, 182, 715, 823, 1512 | #2156400 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | INDEPENDENT PHARMACY COOPERATIVE | NIELSEN MERKSAMER PARRINELLO GROSS & LEONI LLP | $4,000 | $149 | $4,149 | $4,149 | AB 315, 602, 1512; SB 641 | #2157665 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | LANG HANSEN O'MALLEY & MILLER | AEGIS Treatment Centers LLC & Its Affiliated Entities | $30,000 | $0 | $30,000 | $30,000 | AB 395; AB 1512; DRUG MEDI-CAL FUNDING | #2155626 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | MALLINCKRODT, LLC | NOTEWARE GOVERNMENT RELATIONS | $18,000 | $0 | $18,000 | $18,000 | AB 265, AB 1512, SB 17 | #2151401 |
| 01/01/2017–03/31/2017 | Employer Payments to Firms | Matt Back Government Relations | PURDUE PHARMA LP | $21,000 | $0 | $21,000 | $21,000 | Legislature: AB 715; AB 1048; AB 1512; SB 419. | #2155423 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | McKesson Corporation | APREA & MICHELI, INC. | $31,500 | $81 | $31,581 | $31,581 | Legislature re: AB 29, 40, 182, 265, 315, 401, 444, 587, 715, 1048, 1512 and SB 17, 176, 212, 419, 443 | #2156067 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | PFIZER, INC. | KAHN CONSULTING; CHRIS | $48,000 | $0 | $48,000 | $48,000 | CALIFORNIA STATE LEGISLATURE REGARDING: SB 17, SB 212, SB 419, AB 265, AB 587, AB 1353, AB 1512. | #2156391 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Pharmaceutical Research and Manufacturers of America | GLADFELTY GOVERNMENT RELATIONS | $39,250 | $511 | $39,761 | $39,761 | AB265 AB315 AB1512 SB17 | #2151784 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Purdue Pharma LP | Matt Back Government Relations | $21,000 | $0 | $21,000 | $21,000 | Lobbied the Legislature regarding AB 715, AB 1048, AB 1512, and SB 419. | #2152096 |
| 01/01/2017–03/31/2017 | Firm Activity (payments) | Teva Pharmaceuticals USA, Inc. | Aaron Read & Associates, LLC | $32,000 | $0 | $32,000 | $32,000 | AB 1512, SB 17 | #2155522 |